Abstract
Even after the advent of nerve-sparing procedure a significant percent of patients still develop erectile dysfunction after radical prostatectomy [1]. Modifications in the surgical technique of robotic radical prostatectomy have aimed not only to spare the cavernous nerve but also to minimize any potential harm done from manipulation, traction, or thermal injury of the nerves in addition to sparing the microcirculation surrounding the prostate. The adjunctive measures to optimize early return of erectile function can be subdivided into intraoperative measures designed to optimize nerve preservation and minimize injury to the neurovascular structures surrounding the prostate, and postoperative penile rehabilitation to facilitate early return of erectile function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dubbelman D, Dohle R, Schroder H. Sexual function before and after radical retropubic prostatectomy: a systemic review of prognostic indicators for successful outcome. Eur Urol. 2006;50:711–8.
Mulhall J. Defining and reporting erectile function outcomes after radical prostatectomy: challenges and miscoceptions. J Urol. 2009;181:462–71.
Dahm P, Stoffs T, Canfield SE. Recovery of erectile function after robotic prostatectomy:evidence based outcomes. Urol Clin N Am. 2011;38(24):6.
Fairbain NG, Redmond RW. The clinical application of human amnion in plastic surgery. J Plast Reconstr Aesthet Surg. 2014;67(5):665–75.
Fesli A, Yilmaz N, Comelekoglu U, Tasdelen B. Enhancement of nerve healing with the combined use of amniotic membrane and granulocyte colony stimulation factor. J Plast Reconstr Aesthet Surg. 2014;67(5):837–43.
Kim N, Verdi Y, Padma-Nathan H, Daley J, Goldstein I, Saenz de Tejada I. Oxygen tension regulates the nitric oxide pathway. Physiologic role in penile erection. J Clin Invest. 1993;91:437–42.
Klein L, Miller M, Buttyan R, et al. Apoptosis in the rat penis after penile denervation. J Urol. 1997;158:626–30.
Lue T, Tanagho E. Physiology of erection and pharmacological management of impotence. J Urol. 1987;137:829–36.
Mulhall J, Slovick R, Hotaling J, et al. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with recovery of erectile function. J Urol. 2002;167:1371–5.
Montorsi F, Guazzoni G, Strambi LF, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol. 1997;158:1408–10.
Nandipati K, Raina R, Agarwal A, et al. Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections. Int J Impot Res. 2006;18:446–51.
Bannowsky A, Schulze H, van der Horst C, et al. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int. 2008;101:1279–83.
Mulhall J, Land S, Parker M, et al. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med. 2005;2:532–40. discussion 540–2.
Padma-Nathan H, McCullough AR, Levine LA, Lipshultz LI, Siegel R, et al. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res. 2008;20:479–86.
Mulhall JP, Burnett AL, Wang R, McVary KT, Moul JW, et al. A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy. J Urol. 2013;189:2229–36.
Teloken P, Mesquita G, Montorsi F, Mulhall J. Post-radical prostatectomy pharmacological penile rehabilitation: practice patterns among the international society for sexual medicine practitioners. J Sex Med. 2009;6(7):2032–8.
Mulhall JP, Bella AJ, Briganti A, McCullough A, Brock G. Erectile function rehabilitation in the radical prostatectomy patient. J Sex Med. 2010;7(4 Pt 2):1687–98.
Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol. 2004;171(2 Pt 1):771–4.
Köhler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P, et al. A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int. 2007;100(4):858–62.
Raina R, Agarwal A, Ausmundson S, Lakin M, Nandipati KC, Montague DK, et al. Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int J Impot Res. 2006;18(1):77–81.
Chung E, Brock G. Sexual rehabilitation and cancer survivorship: a state of art review of current literature and management strategies in male sexual dysfunction among prostate cancer survivors. J Sex Med. 2013;10 Suppl 1:102–11.
Salonia A, Burnett AL, Graefen M, Hatzimouratidis K, Montorsi F, Mulhall JP, et al. Prevention and management of postprostatectomy sexual dysfunctions. Part 1: choosing the right patient at the right time for the right surgery. Eur Urol. 2012;62(2):261–72.
Chung E, Brock GB. Emerging and novel therapeutic approaches in the treatment of male erectile dysfunction. Curr Urol Rep. 2011;12(6):432–43.
GarcÃa-Cardoso J, Vela R, Mahillo E, Mateos-Cáceres PJ, Modrego J, Macaya C, et al. Increased cyclic guanosine monophosphate production and endothelial nitric oxide synthase level in mononuclear cells from sildenafil citrate-treated patients with erectile dysfunction. Int J Impot Res. 2010;22(1):68–76.
Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2008;54:924–31.
Montorsi F, Brock G, Stolzenburg JU, Mulhall J, Moncada I, et al. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT). Eur Urol. 2014;65:587–96.
Natali A, Masieri L, Lanciotti M, Giancane S, Vignolini G, Carini M, et al. A comparison of different oral therapies versus no treatment for erectile dysfunction in 196 radical nerve-sparing radical prostatectomy patients. Int J Impot Res. 2015;27(1):1–5.
Segal R, Burnett AL. Avanafil for the treatment of erectile dysfunction. Drugs Today. 2012;48(1):7–15.
Paick JS, Kim JJ, Kim SC, et al. Efficacy and safety of mirodenafil in men taking antihypertensive medications. J Sex Med. 2010;7(9):3143–52.
Toque HA, Teixeira CE, Lorenzetti R, Okuyama CE, Antunes E, De Nucci G. Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum. Eur J Pharmacol. 2008;591(1–3):189–95.
Alba F, Wang R. Current status of penile rehabilitation after radical prostatectomy. J Urol. 2010;16:93–101.
McCullough AR, Hellstrom WG, Wang R, Lepor H, Wagner KR, Engel JD. Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate. J Urol. 2010;183:2451–6.
Albersen M, Shindel AW, Lue TF. Sexual dysfunction in the older man. Rev Clin Gerontol. 2009;19(4):237–48.
Raina R, Pahlajani G, Agarwal A, Zippe CD. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity. BJU Int. 2007;100(6):1317–21.
Burnett AL. Erectile dysfunction following radical prostatectomy. JAMA. 2005;293:2648–53.
Claro JA, de Aboim JE, MarÃngolo M, Andrade E, Aguiar W, Nogueira M, et al. Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study. Sao Paulo Med J. 2001;119:135–7.
Gontero P, Fontana F, Bagnasacco A, Panella M, Kocjancic E, Pretti G, et al. Is there an optimal time for intracavernous prostaglandin E1 rehabilitation following nonnerve sparing radical prostatectomy? Results from a hemodynamic prospective study. J Urol. 2003;169(6):2166–9.
Mulhall JP, Parker M, Waters BW, Flanigan R. The timing of penile rehabilitation after bilateral nerve-sparing radical prostatectomy affects the recovery of erectile function. BJU Int. 2010;105:37–41.
Yiou R, Tow BZ, Parisot J, et al. Is it worth continuing sexual rehabilitation after radical prostatectomy with intracavernous injection of alprostadil for more than 1 year? J Sex Med. 2015;3:42–8.
Lewis R, Witherington R. External vacuum therapy for erectile dysfunction: use and results. World J Urol. 1997;15:78–82.
Brison D, Seftel A, Sadeghi-Nejad H. The resurgence of the vacuum erection device (VED) for treatment of erectile dysfunction. J Sex Med. 2013;10:1124–35.
Lin H, Yang W, Zhang J, Dai Y, Wang R. Penile rehabilitation with a vacuum erectile device in an animal model is related to an antihypoxic mechanism: blood gas evidence. Asian J Androl. 2013;15:387–90.
Yuan J, Hoang A, Romero C, Lin H, Dai Y, Wang R. Vacuum therapy in erectile dysfunction—science and clinical evidence. Int J Impot Res. 2010;22:211–9.
Yuan J, Lin H, Li P, Zhang R, Luo A, Berardinelli F, et al. Molecular mechanisms of vacuum therapy in penile rehabilitation: a novel animal study. Eur Urol. 2010;58:773–80.
Yuan J, Westney O, Wang R. Design and application of a new rat-specific vacuum erectile device for penile rehabilitation research. J Sex Med. 2009;6:3247–53.
Monga M, Utz W, Reddy P, Kohler T, Hendlin K, et al. Early use of the vacuum constriction device following radical retropubic prostatectomy: a randomized clinical trial south central section of the AUA 85th annual meeting; 2006. p. 98.
Bosshardt RJ, Farwerk R, Sikora R, Sohn M, Jakse G. Objective measurement of the effectiveness, therapeutic success and dynamic mechanisms of the vacuum device. Br J Urol. 1995;75:786–91.
Gontero P, Fontana F, Zitella A, Montorsi F, Frea B. A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy. BJU Int. 2005;95:359–65.
Raina R, Agarwal A, Allamaneni SS, Lakin MM, Zippe CD. Sildenafil citrate and vacuum constriction device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy. Urology. 2005;65:360–4.
Raina R, Pahlajani G, Agarwal A, Jones S, Zippe C. Long-term potency after early use of a vacuum erection device following radical prostatectomy. BJU Int. 2010;106:1719–22.
Engel JD. Effect on sexual function of a vacuum erection device post-prostatectomy. Can J Urol. 2011;18:5721–5.
Basal S, Wambi C, Acikel C, Gupta M, Badani K. Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function. BJU Int. 2013;111:658–65.
Montorsi F, Adaikan G, Becher E, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2010;7(11):3572–88.
Stein M, Lin H. New advances in erectile technology. Ther Adv Urol. 2014;6(1):15–24.
Lim P. Recent advances and research updates. 2003. ISSN-0972-4689.
Le B, Colombo A, Mustoe T, McVary K. Evaluation of a Ni-Ti shape memory alloy for use in a novel penile prosthesis. J Urol. 2013;189(Suppl):502.
Swords K, Martinez D, Lockhart J, Carrion R. A preliminary report on the usage of an intracorporeal antibiotic cast with synthetic high purity CaSO4 for the treatment of infected penile implant. J Sex Med. 2013;10:1162–9.
Yap RL, Mcvary KT. Topical agents and erectile dysfunction: is there a place? Curr Urol Rep. 2002;3:471–6.
Montorsi F, Salonia A, Zanoni M, Pompa P, Cestari A, Guazzoni G, et al. Current status of local penile therapy. Int J Impot Res. 2002;14(1 suppl):S70–81.
Friedman AJ, Han G, Navati MS, Chacko M, Gunther L, Alfieri A, et al. Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide. 2008;19:12–20.
Gupta R, Kumar A. Bioactive materials for biomedical applications using sol-gel technology. Biomed Mater. 2008;3:034005.
Khan I, Dantsker D, Samuni U, Friedman AJ, Bonaventura C, Manjula B, et al. Beta 93 modified hemoglobin: kinetic and conformational consequences. Biochemistry. 2001;40:7581–92.
Khan I, Shannon CF, Dantsker D, Friedman AJ, Perez-Gonzalez-de-Apodaca J, Friedman JM. Sol-gel trapping of functional intermediates of hemoglobin: geminate and bimolecular recombination studies. Biochemistry. 2000;39:16099–109.
Viitala R, Jokinen M, Rosenholm JB. Mechanistic studies on release of large and small molecules from biodegradable SiO2. Int J Pharm. 2007;336:382–90.
Han G, Tar M, Kuppam D, Friedman A, Melman A, Friedman J, et al. Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction. J Sex Med. 2010;7:224–33.
Davies KP, Tar M, Rougeot C, Melman A. Sialorphin (the mature peptide product of Vcsa1) relaxes corporal smooth muscle tissue and increases erectile function in the ageing rat. BJU Int. 2007;99:431–5.
Seftel AD. Phosphodiesterase type 5 inhibitor differentiation based on selectivity, pharmacokinetic, and efficacy profiles. Clin Cardiol. 2004;27(4 suppl 1):114–9.
Jetter A, Kinzig-Schippers M, Walchner-Bonjean M, Hering U, Bulitta J, Schreiner P, et al. Effects of grapefruit juice on the pharmacokinetics of sildenafil. Clin Pharmacol Ther. 2002;71:21–9.
Young S, Dyson M. The effect of therapeutic ultrasound on angiogenesis. Ultrasound Med Biol. 1990;16:261–9.
Qiu X, Lin G, Xin Z, Ferretti L, Zhang H, Lue T, et al. Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. J Sex Med. 2013;10:738–46.
Wang C, Huang H, Pai C. Shock wave-enhanced neovascularization at the tendon-bone junction: an experiment in dogs. J Foot Ankle Surg. 2002;41:16–22.
Wang C, Wang F, Yang K, Weng L, Hsu C, Huang C, et al. Shock wave therapy induces neovascularization at the tendon-bone junction. A study in rabbits. J Orthop Res. 2003;21:984–9.
Gutersohn A, Caspari G, Vopahl M, Erbel R. Upregulation of VEGF mRNA in HUVEC via shock waves. In: Proceedings of the international conference from genes to therapy in ischemic and heart muscle disease, Marburg, Germany, 9–10 Oct 1999.
Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe T, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation. 2004;110:3055–61.
Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher A, Dimmeler S. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation. 2006;114:2823–30.
Vardi Y, Appel B, Jacob G, Massarwi O, Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010;58:243–8.
Vardi Y, Appel B, Kilchevsky A, Gruenwald I. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol. 2012;187:1769–75.
Walz J, Burnett AL, Costello AJ, Eastham JA, Graefen M, Guillonneau B, et al. A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol. 2010;57:179–92.
Rogers CG, Trock BP, Walsh PC. Preservation of accessory pudendal arteries during radical retropubic prostatectomy: surgical technique and results. Urology. 2004;64:148–51.
Mulhall JP, Secin FP, Guillonneau B. Artery sparing radical prostatectomy – myth or reality? J Urol. 2008;179:827–31.
Moreland RB. Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res. 1998;10:113–20.
Nehra A, Hall SJ, Basile G, Bertero EB, Moreland R, Toselli P, et al. Systemic sclerosis and impotence: a clinicopathological correlation. J Urol. 1995;153:1140–6.
Pelka R, Jaenicke C, Gruenwald J. Impulse magnetic-field therapy for erectile dysfunction: a double-blind, placebo-controlled study. Adv Ther. 2002;19:53–60.
Shafik A, El-Sibai O, Shafik A. Magnetic stimulation of the cavernous nerve for the treatment of erectile dysfunction in humans. Int J Impot Res. 2000;12:137–41. discussion 141–132.
Tajkarimi K, Burnett A. Viberect® device use by men with erectile dysfunction: safety, ease of use, tolerability, and satisfaction survey. J Sex Med. 2011;8:441.
Fode M, Borre M, Ohl DA, Lichtbach J, Sønksen J. Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial. BJU Int. 2014;114:111–7.
Yoo J, Lee I, Atala A. Cartilage rods as a potential material for penile reconstruction. J Urol. 1998;160:1164–8. discussion 1178.
Yoo J, Park H, Lee I, Atala A. Autologous engineered cartilage rods for penile reconstruction. J Urol. 1999;162:1119–21.
Kershen R, Yoo J, Moreland R, Krane R, Atala A. Reconstitution of human corpus cavernosum smooth muscle in vitro and in vivo. Tissue Eng. 2002;8:515–24.
Chen K, Eberli D, Yoo J, Atala A. Bioengineered corporal tissue for structural and functional restoration of the penis. Proc Natl Acad Sci U S A. 2010;107:3346–50.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Nerve preservation judicious use of thermal energy with dHam wrap (MP4 199313 kb)
Optimizing erectile function with accessory pudendal artery preservation and judicious use of thermal energy (MP4 75084 kb)
First in the world use of amniotic membrane in robotic prostatectomy for early return of erections (MP4 116775 kb)
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Boudiab, N., Khater, U., Razdan, S., Razdan, S. (2016). Adjunctive Measures and New Therapies to Optimize Early Return of Erectile Function. In: Razdan, S. (eds) Urinary Continence and Sexual Function After Robotic Radical Prostatectomy. Springer, Cham. https://doi.org/10.1007/978-3-319-39448-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-39448-0_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-39446-6
Online ISBN: 978-3-319-39448-0
eBook Packages: MedicineMedicine (R0)